Article Information
History
- October 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Stefania Capone1,#,
- Francesco M. Fusco2,
- Stefano Milleri3,
- Silvio Borrè4,
- Sergio Carbonara5,
- Sergio Lo Caputo6,
- Sebastiano Leone7,
- Giovanni Gori8,
- Paolo Maggi9,
- Antonio Cascio10,
- Miriam Lichtner11,
- Roberto Cauda12,
- Sarah Dal Zoppo13,
- Maria V. Cossu14,
- Andrea Gori15,16,
- Silvia Roda17,
- Paola Confalonieri18,
- Stefano Bonora19,
- Gabriele Missale20,21,
- Mauro Codeluppi22,
- Ivano Mezzaroma23,
- Serena Capici24,
- Emanuele Pontali25,
- Marco Libanore26,
- Augusta Diani27,
- Simone Lanini28,
- Simone Battella1,
- Alessandra M. Contino1,
- Eva Piano Mortari29,
- Francesco Genova1,
- Gessica Parente1,
- Rosella Dragonetti1,
- Stefano Colloca1,
- Luigi Visani30,
- Claudio Iannacone31,
- Rita Carsetti29,
- Antonella Folgori1,
- Roberto Camerini1,
- COVITAR study group*
- 1ReiThera srl – Castel Romano, Rome, Italy
- 2“D. Cotugno” Hospital, Azienda Specialistica dei Colli, Naples, Italy
- 3Centro Ricerche Cliniche di Verona- CRC, Verona, Italy
- 4ASL Vercelli Malattie Infettive, Vercelli, Italy
- 5U.O.C. Malattie Infettive – P.O. V. Emanuele II, Bisceglie (BT), Italy
- 6Malattie infettive, Dipartimento di Scienze Mediche e Chirurgiche - A.O. U. Policlinico Foggia, Italy
- 7Division of Infectious Diseases, San Giuseppe Moscati Hospital, Avellino, Italy
- 8Centro di Farmacologia Clinica per la Sperimentazione dei Farmaci - Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
- 9Università degli Studi della Campania Luigi Vanvitelli, Caserta, Italy
- 10Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy
- 11Dept NESMOS Sapienza University of Rome, Infectious Disease Unit, SM Goretti Hospital, Latina, Italy
- 12Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- 13UO Malattie Infettive, ASST Cremona, Italy
- 14I Divisione Malattie Infettive- ASST FBF SACCO, Milan, Italy
- 15Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
- 16Infectious Diseases Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- 17U.O.C. Malattie Infettive - Fondazione IRCCS Policlinico San Matteo di Pavia, Italy
- 18Struttura Complessa Pneumologia - Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy
- 19Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Italy
- 20Department of Medicine and Surgery, University of Parma, Parma, Italy
- 21Unit of Infectious Diseases and Hepatology – Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
- 22UOC di Malattie Infettive - Ospedale Guglielmo da Saliceto – AUSL Piacenza, Italy
- 23UOC Malattie Infettive, AOU Policlinico Umberto 1; Dept of Translational and Precision Medicine, Sapienza University of Roma, Italy
- 24Phase 1 Research Unit, ASST Monza, Monza, Italy
- 25Department of Infectious Diseases - E.O. Ospedali Galliera – Genova, Italy
- 26Department Infectious Diseases St Anna Hospital and University Ferrara, Italy
- 27Ospedale di Circolo e Fondazione Macchi – Varese, Italy
- 28INMI Spallanzani – Rome, Italy
- 29B Cell Unit, Immunology Research Area, Bambino Gesù Children’s Hospital, IRCCS, Viale di San Paolo, 00146 Rome, Italy
- 30Exom-Group Milan, Italy
- 31SPARC Consulting, Milan, Italy
- ↵#Correspondence to: Stefania Capone, Department of Preclinical and Clinical Immunology, ReiThera srl, Rome, 00128, Italy; Phone: +39 06 99775399; Email stefania.capone{at}reithera.com
Posted October 10, 2022.
GRAd-COV2 vaccine provides potent and durable immunity in randomised placebo-controlled phase 2 trial (COVITAR)
